Skip to content

安耐森

US · ANNX #3455 按市值排名 上市于 2020
3.41 -0.19 -5.28%
实时 - 追踪5344个代码 - 心跳于351秒前 · 2026-10-16 19:30

✦ 量化股权信号 计算方式说明

减持
  • 机构持股总比例下降了7.3个百分点。

机构持股

机构持股比例
101.85% -7.34pp
机构数量
252
数据截至
2026/Q3 较上一报告期

持股变动 vs 资金流向

方向一致

机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund49.32%
Hedge Fund32.46%
VC/PE Fund13.44%
Public Company4.34%
Insurance Company1.17%
Individual/Insider0.92%
Private Company0.48%
Government Pension Fund0.37%
Endowment Fund0.25%

主要股东 截至 2026-06-30

FMR 10.30% · 19.52M 股
Redmile Group, LLC 7.67% · 14.55M 股
BlackRock 7.14% · 13.54M 股
State Street Global Advisors 5.18% · 9.82M 股
Alerce Investment Management L.P. 5.03% · 9.53M 股
BVF Partners L.P. 4.59% · 8.70M 股
Vanguard Capital Management, LLC 4.21% · 7.98M 股
Woodline Partners LP 3.65% · 6.93M 股
MAK Capital One, LLC 3.09% · 5.86M 股
Artal Group S.A. 2.35% · 4.46M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 34次买入 · 16次卖出

姓名职务持股比例
Muneer Satter Independent Director 0.43%
Douglas Love Chief Executive Officer 0.21%
Ted Yednock Executive VP, Chief Innovation Officer & Chairman of the Scientific Advisory Board 0.10%
William Carson Independent Director 0.04%
Michael Overdorf Executive VP & Chief Business Officer 0.04%
Dean Artis Chief Scientific Officer & Executive VP 0.04%
Jennifer Lew Chief Financial Officer 0.03%
Jung Choi Independent Director 0.02%
Jamie Dananberg Chief Medical Officer 0.01%
Thomas Wiggans Independent Chairperson --

内部人交易 最近的 Form 4 申报记录

日期姓名职务类型股数价格
2026-09-23 Douglas Love Chief Executive Officer Open Market Acquisition +26,065 $3.83
2026-08-12 Thomas Wiggans Independent Chairperson Intent to Sell (Form 144) -2,000 $5.30
2026-08-09 Mark Blumenkranz Director Other Derivative Acquisition +175,000 $5.39
2026-07-14 Thomas Wiggans Independent Chairperson Intent to Sell (Form 144) -2,000 $6.32
2026-07-13 Thomas Wiggans Independent Chairperson Intent to Sell (Form 144) -1,000 $5.61
2026-06-10 Muneer Satter Independent Director Other Derivative Acquisition +65,000 $4.70
2026-06-10 Jung Choi Independent Director Other Derivative Acquisition +65,000 $4.70
2026-06-10 William Waddill Independent Director Other Derivative Acquisition +65,000 $4.70
2026-06-10 Ted Yednock Executive VP, Chief Innovation Officer & Chairman of the Scientific Advisory Board Derivative Exercise and Retained +30,646 $1.85
2026-06-10 William Jones Director Other Derivative Acquisition +65,000 $4.70
2026-06-10 William Carson Independent Director Other Derivative Acquisition +65,000 $4.70
2026-06-10 Bettina Cockroft Independent Director Other Derivative Acquisition +65,000 $4.70
2026-05-27 Alerce Investment Management L.P. -- Open Market Acquisition +613,497 $5.41
2026-05-10 William Carson Independent Director Automatic Acquisition +8,000 $5.78
2026-04-09 William Carson Independent Director Automatic Acquisition +8,000 $6.20
2026-03-09 William Carson Independent Director Automatic Acquisition +8,000 $5.67
2026-03-01 Dean Artis Chief Scientific Officer & Executive VP Open Market Disposition -5,894 $5.43
2026-03-01 Ted Yednock Executive VP, Chief Innovation Officer & Chairman of the Scientific Advisory Board Open Market Disposition -5,566 $5.42
2026-03-01 Jennifer Lew Chief Financial Officer Open Market Disposition -5,565 $5.42
2026-03-01 Jamie Dananberg Chief Medical Officer Open Market Disposition -5,820 $5.43

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:30:04 · 仅供参考，不构成投资建议，也未考虑您的具体情况。

安耐森 讨论区 0 条评论

发表评论